The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.

Tetsuya HanakaTakashi KidoShingo NoguchiSohsuke YamadaHirotsugu NoguchiXin GuoAya NawataKe-Yong WangKeishi OdaTsutomu TakakiHiroto IzumiHiroshi IshimotoKazuhiro YateraHiroshi Mukae

Published in: BMC pulmonary medicine (2019)

PRDX4 is associated with the aggravation of inflammatory changes and fibrosis in the pathogenesis of IPF, and serum PRDX4 may be useful in clinical practice of IPF patients.

Keyphrases

idiopathic pulmonary fibrosis
end stage renal disease
interstitial lung disease
clinical practice
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
cell proliferation
transcription factor
patient reported outcomes
patient reported